Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-08

Clinical Trial Update: Place Controlled Study to Treat Recurrent Herpes Labialis. [Phase 2]

View source ↗

Summary

A Phase 2, placebo-controlled study evaluating treatment for recurrent herpes labialis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Zurich | Conditions: Recurrent Herpes Labialis | Phase 2 | Status: COMPLETED